Oxygenta Pharmaceutical Limited (BOM:524636)
India flag India · Delayed Price · Currency is INR
67.43
+2.05 (3.14%)
At close: Aug 17, 2026

Oxygenta Pharmaceutical Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
2,4941,7892,942971520342
Market Cap Growth
-25.08%-39.19%203.13%86.75%52.18%358.63%
Enterprise Value
3,5682,5053,5481,5141,108854
Last Close Price
67.4348.3879.5628.9936.6024.05

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
1.851.582.662.451.680.56
PB Ratio
-5.84-4.19-11.48-4.82-1.12-0.99
P/OCF Ratio
--103.94---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
2.642.213.213.823.581.41
EV/EBITDA Ratio
-----57.83

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
-2.57-2.57-2.43-2.84-1.47-1.50
Debt / EBITDA Ratio
-----35.32
Net Debt / Equity Ratio
-2.52-2.56-2.43-2.84-1.47-1.50
Net Debt / EBITDA Ratio
-15.13-7.25-7.39-5.91-9.5435.21
Net Debt / FCF Ratio
--2.69-7.27-3.34-6.02-7.84
Asset Turnover
-1.121.510.680.731.86
Inventory Turnover
-4.145.663.193.175.82
Quick Ratio
-0.120.060.290.310.22
Current Ratio
-0.600.360.720.761.19
Return on Assets (ROA)
--10.72%-10.30%-13.14%-13.41%-0.22%
Return on Invested Capital (ROIC)
--113.78%-90.96%-48.55%-41.23%-0.58%
Return on Capital Employed (ROCE)
--51.70%395.40%-41.90%-42.90%-0.50%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-5.44%-9.82%-3.50%-3.58%-22.26%-1.79%
FCF Yield
-16.28%-22.70%-2.91%-17.67%-21.70%-19.40%
Buyback Yield / Dilution
-1.23%-2.89%-12.20%-125.61%-11.43%-24.92%